Since theBRAIN Initiative's
launch in 2013, FAS Research Development has disseminated information via this newsletter about all of the funding opportunities related to the initiative. We send this newsletter to a targeted list of faculty, includingfaculty affiliatesof theCenter for Brain Science(CBS) and theMind Brain Behavior(MBB) Interfaculty Initiative. This project is being carried out in collaboration with the Center for Brain Science. Please feel free to forward this newsletter to interested colleagues. All Harvard University faculty and administrators may subscribe here, and recipients may unsubscribe at any time. In addition, you may access the Science Division Funding Spotlight here. For an archive of past newsletters, or for information about additional Research Development support (finding funding, proposal development resources, etc.), please visit the Research Development website.
Sponsor Deadline for Letters of Intent (requested): 30 days prior to full proposal deadline
FAS/SEAS/OSP Deadline: 5 business days prior to submission
Sponsor Deadlines for Full Proposals: March 24, 2020; June 2, 2020; October 1, 2020; February 2, 2021; June 1, 2021; October 1, 2021; February 1, 2022; June 1, 2022; and October 3, 2022
Award Information: Application budgets are not limited. The maximum project period is 5 years. NIH anticipates providing $10M per year to fund an estimated 10 to 15 awards.
A central goal of the BRAIN Initiative is to develop new and improved technologies suitable for recording from, as well as controlling, specified cell types and circuits to modulate and understand function in the central nervous system. In order to accomplish these goals, further information is needed to understand the function of current technologies used for recording or stimulating the nervous system.
This RFA accepts grant applications in two related but distinct areas. The first is to systematically characterize, model, and validate the membrane, cellular, circuit, and adaptive-biological responses of neuronal and non-neuronal cells to various types of stimulation technologies. The second is to understand the biological and bioinformatic content of signals recorded from neuronal and non-neuronal cells and circuits. Development of new technologies, therapies and disease models is outside the scope of this FOA. Activities related to enabling the simultaneous use of multiple recording or stimulation technologies are allowed.